blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3505156

EP3505156 - MANUFACTURING PROCESS OF CYCLOSPORIN EYE GEL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.10.2021
Database last updated on 17.09.2024
FormerThe patent has been granted
Status updated on  23.10.2020
FormerGrant of patent is intended
Status updated on  18.06.2020
FormerExamination is in progress
Status updated on  17.12.2019
FormerRequest for examination was made
Status updated on  31.05.2019
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Room 501
5th Floor, No. 1, Meide 3rd Road
Pearl River Industrial Park
Nansha District
Guangzhou, Guangdong Province / CN
[N/P]
Former [2021/44]For all designated states
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Room 501, 5th Floor, No. 1
Meide 3rd Road
Pearl River Industrial Park
Nansha District
Guangzhou, Guangdong Province / CN
Former [2019/27]For all designated states
Zhaoke (Guangzhou) Opthalmic Drug
1 Meide 3rd Road, Pearl River, Industrial Park
Nansha District
Guangzhou City
Guangdong 230088 / CN
Inventor(s)01 / Li, Gang
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
02 / Cao, Kailei
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
03 / Li, Xiaoyi
1/F, Buildin g 20E, Phase 3, Hong Kong Science
Park
Shatin / HK
04 / Dai, Xiangrong
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
05 / Yin, Lei
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
06 / Ling, Juan
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
07 / Li, Xiaoyi
1/F, Building 20E, Phase 3,
Hong Kong Science Park
Shatin / HK
 [2020/29]
Former [2019/27]01 / Li, Gang
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
02 / Cao, Kailei
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
03 / Li, Xiaoyi
1/F, Buildin g 20E, Phase 3, Hong Kong Science
Park
Shatin / HK
04 / Dai, Xiangrong
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
05 / Yin, Lei
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
06 / Ling, Juan
No. 30, Tianzhi Road, New and High - Tech
Industrial Development Zone
Hefei City, Anhui 230088 / CN
Representative(s)Isern Patentes y Marcas S.L.
Avda. Diagonal, 463 Bis, 2°
08036 Barcelona / ES
[2019/27]
Application number, filing date18215549.921.12.2018
[2019/27]
Priority number, dateCN20171142789126.12.2017         Original published format: CN201711427891
[2019/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3505156
Date:03.07.2019
Language:EN
[2019/27]
Type: B1 Patent specification 
No.:EP3505156
Date:25.11.2020
Language:EN
[2020/48]
Search report(s)(Supplementary) European search report - dispatched on:EP14.05.2019
ClassificationIPC:A61K9/107, A61K38/13, A61K47/10, A61K47/32, A61K47/44
[2019/27]
CPC:
A61K9/0048 (EP,CN,US); A61K38/13 (EP,CN,US); A61K47/10 (EP,CN,US);
A61K47/32 (EP,CN,US); A61K47/44 (EP,CN,US); A61K9/06 (CN,US);
A61K9/107 (EP,US); A61P27/02 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/27]
TitleGerman:HERSTELLUNGSVERFAHREN VON CYCLOSPORIN-AUGENGEL[2019/27]
English:MANUFACTURING PROCESS OF CYCLOSPORIN EYE GEL[2019/27]
French:PROCÉDÉ DE FABRICATION DE GEL OCULAIRE DE CYCLOSPORINE[2019/27]
Examination procedure21.12.2018Examination requested  [2019/27]
20.12.2019Despatch of a communication from the examining division (Time limit: M04)
17.04.2020Reply to a communication from the examining division
19.06.2020Communication of intention to grant the patent
18.10.2020Fee for grant paid
18.10.2020Fee for publishing/printing paid
18.10.2020Receipt of the translation of the claim(s)
Opposition(s)26.08.2021No opposition filed within time limit [2021/44]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.12.2018
AL25.11.2020
AT25.11.2020
CY25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
MK25.11.2020
MT25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SI25.11.2020
SK25.11.2020
SM25.11.2020
TR25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
[2022/33]
Former [2022/27]HU21.12.2018
AL25.11.2020
AT25.11.2020
CY25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
MT25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SI25.11.2020
SK25.11.2020
SM25.11.2020
TR25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2022/23]AL25.11.2020
AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SI25.11.2020
SK25.11.2020
SM25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2022/10]AL25.11.2020
AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SI25.11.2020
SK25.11.2020
SM25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
PT25.03.2021
Former [2021/50]AL25.11.2020
AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SI25.11.2020
SK25.11.2020
SM25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/47]AL25.11.2020
AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SK25.11.2020
SM25.11.2020
LU21.12.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/45]AL25.11.2020
AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SK25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/40]AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
MC25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SK25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/36]AT25.11.2020
CZ25.11.2020
EE25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SK25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/35]AT25.11.2020
CZ25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
PL25.11.2020
RO25.11.2020
RS25.11.2020
SK25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/33]AT25.11.2020
HR25.11.2020
LT25.11.2020
LV25.11.2020
PL25.11.2020
RS25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/32]AT25.11.2020
HR25.11.2020
LV25.11.2020
PL25.11.2020
RS25.11.2020
SM25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/28]AT25.11.2020
HR25.11.2020
LV25.11.2020
PL25.11.2020
RS25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/25]AT25.11.2020
LV25.11.2020
PL25.11.2020
RS25.11.2020
BG25.02.2021
GR26.02.2021
IS25.03.2021
PT25.03.2021
Former [2021/23]AT25.11.2020
LV25.11.2020
RS25.11.2020
BG25.02.2021
GR26.02.2021
PT25.03.2021
Former [2021/22]RS25.11.2020
PT25.03.2021
Former [2021/21]PT25.03.2021
Documents cited:Search[A]CN1686533  (SHANGHAI INST MATERIA MEDICA [CN]) [A] 1-10 * the whole document *;
 [A]CN101897949  (WINSTON MEDICAL SUPPLY CO LTD) [A] 1-10 * the whole document *;
 [AD]CN103735495  (ZHAOKE PHARMACEUTICAL HEFEI CO LTD) [AD] 1-10 * the whole document *;
 [A]  - YINGQING RAN ET AL, "Solubilization of cyclosporin A", AAPS PHARMSCITECH, (200103), vol. 2, no. 1, doi:10.1208/pt020102, pages 23 - 26, XP055582661 [A] 1-10 * abstract * * page 3; figures 2,3 *

DOI:   http://dx.doi.org/10.1208/pt020102
by applicantCN20141033737
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.